| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Abstract
|
|
|
2012
|
|
4 |
p. 282-
1 p.
|
article
|
| 2 |
Acknowledgments
|
|
|
2012
|
|
4 |
p. 330-
1 p.
|
article
|
| 3 |
A multidisciplinary review of the science of vitamin D receptor activation
|
Cozzolino, Mario
|
|
2011
|
|
4 |
p. 107-110
4 p.
|
article
|
| 4 |
Assessment of cardiovascular risk in hypertensive patients: a comparison of commonly used risk scoring programs
|
Ulusoy, Şükrü
|
|
2013
|
|
4 |
p. 340-342
3 p.
|
article
|
| 5 |
Biographic and Disclosure Information
|
|
|
2012
|
|
4 |
p. 324-329
6 p.
|
article
|
| 6 |
Cardiovascular and other effects of salt consumption
|
Cappuccio, Francesco P.
|
|
2013
|
|
4 |
p. 312-315
4 p.
|
article
|
| 7 |
Cell-based therapies in kidney disease
|
Rosenberg, Mark E.
|
|
2013
|
|
4 |
p. 364-367
4 p.
|
article
|
| 8 |
Chapter 1: Diagnosis and evaluation of anemia in CKD
|
|
|
2012
|
|
4 |
p. 288-291
4 p.
|
article
|
| 9 |
Chapter 4: Red cell transfusion to treat anemia in CKD
|
|
|
2012
|
|
4 |
p. 311-316
6 p.
|
article
|
| 10 |
Chapter 3: Use of ESAs and other agents* * Excluding iron which is discussed in Chapter 2. to treat anemia in CKD
|
|
|
2012
|
|
4 |
p. 299-310
12 p.
|
article
|
| 11 |
Chapter 2: Use of iron to treat anemia in CKD
|
|
|
2012
|
|
4 |
p. 292-298
7 p.
|
article
|
| 12 |
Committees
|
|
|
2013
|
|
4 |
p. 383-388
6 p.
|
article
|
| 13 |
Controlling hypertension in Turkey: not a hopeless dream
|
Sengul, Sule
|
|
2013
|
|
4 |
p. 326-331
6 p.
|
article
|
| 14 |
Early diagnosis saves lives: focus on patients with chronic kidney disease
|
Ecder, Tevfik
|
|
2013
|
|
4 |
p. 335-336
2 p.
|
article
|
| 15 |
Early diagnosis saves lives: focus on patients with hypertension
|
Gulec, Sadi
|
|
2013
|
|
4 |
p. 332-334
3 p.
|
article
|
| 16 |
Fibroblast growth factor-23 and Klotho in chronic kidney disease
|
Vervloet, Marc G.
|
|
2011
|
|
4 |
p. 130-135
6 p.
|
article
|
| 17 |
Fifteenth national congress of the Turkish Society of Hypertension and Renal Diseases
|
Sengul, Sule
|
|
2013
|
|
4 |
p. 307-
1 p.
|
article
|
| 18 |
Foreword
|
|
|
2012
|
|
4 |
p. 280-
1 p.
|
article
|
| 19 |
Home and ambulatory blood pressure monitoring: when? who?
|
Kantarci, Gülçin
|
|
2013
|
|
4 |
p. 337-339
3 p.
|
article
|
| 20 |
How to determine ‘dry weight’?
|
Gunal, Ali I.
|
|
2013
|
|
4 |
p. 377-379
3 p.
|
article
|
| 21 |
Hypertension and chronic kidney disease in Turkey
|
Sengul, Sule
|
|
2013
|
|
4 |
p. 308-311
4 p.
|
article
|
| 22 |
Hypertension in women
|
Hage, Fadi G.
|
|
2013
|
|
4 |
p. 352-356
5 p.
|
article
|
| 23 |
Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation
|
Dusso, Adriana S.
|
|
2011
|
|
4 |
p. 136-141
6 p.
|
article
|
| 24 |
Methods for guideline development
|
|
|
2012
|
|
4 |
p. 317-323
7 p.
|
article
|
| 25 |
Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation
|
Bover, Jordi
|
|
2011
|
|
4 |
p. 122-129
8 p.
|
article
|
| 26 |
Notice
|
|
|
2012
|
|
4 |
p. 279-
1 p.
|
article
|
| 27 |
Novel strategies for treatment of resistant hypertension
|
Judd, Eric K.
|
|
2013
|
|
4 |
p. 357-363
7 p.
|
article
|
| 28 |
Oral Presentations
|
|
|
2013
|
|
4 |
p. 392-409
18 p.
|
article
|
| 29 |
Pharmacological and non-pharmacological treatment of hypertension in dialysis patients
|
Ozkahya, Mehmet
|
|
2013
|
|
4 |
p. 380-382
3 p.
|
article
|
| 30 |
Poster Presentations
|
|
|
2013
|
|
4 |
p. 410-417
8 p.
|
article
|
| 31 |
Rational approaches to the treatment of hypertension: diet
|
Duman, Soner
|
|
2013
|
|
4 |
p. 343-345
3 p.
|
article
|
| 32 |
Rational approaches to the treatment of hypertension: drug therapy—monotherapy, combination, or fixed-dose combination?
|
Canbakan, Başol
|
|
2013
|
|
4 |
p. 349-351
3 p.
|
article
|
| 33 |
Rational approaches to the treatment of hypertension: modification of lifestyle measures
|
Sayarlioglu, Hayriye
|
|
2013
|
|
4 |
p. 346-348
3 p.
|
article
|
| 34 |
References
|
|
|
2012
|
|
4 |
p. 331-335
5 p.
|
article
|
| 35 |
Risk factors for chronic kidney disease: an update
|
Kazancioğlu, Rumeyza
|
|
2013
|
|
4 |
p. 368-371
4 p.
|
article
|
| 36 |
Salt and hypertension: why is there still a debate?
|
Batuman, Vecihi
|
|
2013
|
|
4 |
p. 316-320
5 p.
|
article
|
| 37 |
Scientific Program
|
|
|
2013
|
|
4 |
p. 389-391
3 p.
|
article
|
| 38 |
Slowing progression of chronic kidney disease
|
Drawz, Paul E.
|
|
2013
|
|
4 |
p. 372-376
5 p.
|
article
|
| 39 |
Summary of Recommendation Statements
|
|
|
2012
|
|
4 |
p. 283-287
5 p.
|
article
|
| 40 |
Ten years of progress in our understanding of uremic vascular calcification and disease: a decade summarized in 20 steps
|
Brandenburg, Vincent M.
|
|
2011
|
|
4 |
p. 116-121
6 p.
|
article
|
| 41 |
Translational studies on augmentation of intratubular renin–angiotensin system in hypertension
|
Navar, L. Gabriel
|
|
2013
|
|
4 |
p. 321-325
5 p.
|
article
|
| 42 |
Vitamin D deficiency and heart disease
|
Pilz, Stefan
|
|
2011
|
|
4 |
p. 111-115
5 p.
|
article
|
| 43 |
Work Group Membership
|
|
|
2012
|
|
4 |
p. 281-
1 p.
|
article
|
Journal description